175 related articles for article (PubMed ID: 21493592)
1. Histone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated state.
Lee MH; Jothi M; Gudkov AV; Mal AK
Cancer Res; 2011 Jun; 71(11):3921-31. PubMed ID: 21493592
[TBL] [Abstract][Full Text] [Related]
2. p38α MAPK disables KMT1A-mediated repression of myogenic differentiation program.
Chatterjee B; Wolff DW; Jothi M; Mal M; Mal AK
Skelet Muscle; 2016; 6():28. PubMed ID: 27551368
[TBL] [Abstract][Full Text] [Related]
3. Camptothecin exhibits topoisomerase1-independent KMT1A suppression and myogenic differentiation in alveolar rhabdomyosarcoma cells.
Wolff DW; Lee MH; Jothi M; Mal M; Li F; Mal AK
Oncotarget; 2018 May; 9(40):25796-25807. PubMed ID: 29899822
[TBL] [Abstract][Full Text] [Related]
4. SNAIL is a key regulator of alveolar rhabdomyosarcoma tumor growth and differentiation through repression of MYF5 and MYOD function.
Skrzypek K; Kusienicka A; Trzyna E; Szewczyk B; Ulman A; Konieczny P; Adamus T; Badyra B; Kortylewski M; Majka M
Cell Death Dis; 2018 May; 9(6):643. PubMed ID: 29844345
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase 3β represses MYOGENIN function in alveolar rhabdomyosarcoma.
Dionyssiou MG; Ehyai S; Avrutin E; Connor MK; McDermott JC
Cell Death Dis; 2014 Feb; 5(2):e1094. PubMed ID: 24577092
[TBL] [Abstract][Full Text] [Related]
6. EHMT1 promotes tumor progression and maintains stemness by regulating ALDH1A1 expression in alveolar rhabdomyosarcoma.
Nachiyappan A; Soon JLJ; Lim HJ; Lee VK; Taneja R
J Pathol; 2022 Mar; 256(3):349-362. PubMed ID: 34897678
[TBL] [Abstract][Full Text] [Related]
7. Histone methyltransferase Suv39h1 represses MyoD-stimulated myogenic differentiation.
Mal AK
EMBO J; 2006 Jul; 25(14):3323-34. PubMed ID: 16858404
[TBL] [Abstract][Full Text] [Related]
8. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.
Coda DM; Lingua MF; Morena D; Foglizzo V; Bersani F; Ala U; Ponzetto C; Taulli R
Cell Cycle; 2015; 14(9):1389-402. PubMed ID: 25644430
[TBL] [Abstract][Full Text] [Related]
9. The Wnt-pathway corepressor TLE3 interacts with the histone methyltransferase KMT1A to inhibit differentiation in Rhabdomyosarcoma.
Kalita B; Sahu S; Bharadwaj A; Panneerselvam L; Martinez-Cebrian G; Agarwal M; Mathew SJ
Oncogene; 2024 Feb; 43(7):524-538. PubMed ID: 38177411
[TBL] [Abstract][Full Text] [Related]
10. p38-{gamma}-dependent gene silencing restricts entry into the myogenic differentiation program.
Gillespie MA; Le Grand F; Scimè A; Kuang S; von Maltzahn J; Seale V; Cuenda A; Ranish JA; Rudnicki MA
J Cell Biol; 2009 Dec; 187(7):991-1005. PubMed ID: 20026657
[TBL] [Abstract][Full Text] [Related]
11. AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cell.
Jothi M; Nishijo K; Keller C; Mal AK
Cell Cycle; 2012 Mar; 11(5):895-908. PubMed ID: 22333587
[TBL] [Abstract][Full Text] [Related]
12. The p38 MAPK family, a pushmi-pullyu of skeletal muscle differentiation.
Lassar AB
J Cell Biol; 2009 Dec; 187(7):941-3. PubMed ID: 20026653
[TBL] [Abstract][Full Text] [Related]
13. Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma.
Pomella S; Sreenivas P; Gryder BE; Wang L; Milewski D; Cassandri M; Baxi K; Hensch NR; Carcarino E; Song Y; Chou HC; Yohe ME; Stanton BZ; Amadio B; Caruana I; De Stefanis C; De Vito R; Locatelli F; Chen Y; Chen EY; Houghton P; Khan J; Rota R; Ignatius MS
Nat Commun; 2021 Jan; 12(1):192. PubMed ID: 33420019
[TBL] [Abstract][Full Text] [Related]
14. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
15. Tip60 regulates myoblast differentiation by enhancing the transcriptional activity of MyoD via their physical interactions.
Kim JW; Jang SM; Kim CH; An JH; Kang EJ; Choi KH
FEBS J; 2011 Nov; 278(22):4394-404. PubMed ID: 21936881
[TBL] [Abstract][Full Text] [Related]
16. DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation.
Megiorni F; Camero S; Ceccarelli S; McDowell HP; Mannarino O; Marampon F; Pizer B; Shukla R; Pizzuti A; Marchese C; Clerico A; Dominici C
Oncotarget; 2016 Nov; 7(48):79342-79356. PubMed ID: 27764816
[TBL] [Abstract][Full Text] [Related]
17. The histone demethylase KDM4B interacts with MyoD to regulate myogenic differentiation in C2C12 myoblast cells.
Choi JH; Song YJ; Lee H
Biochem Biophys Res Commun; 2015 Jan; 456(4):872-8. PubMed ID: 25534856
[TBL] [Abstract][Full Text] [Related]
18. A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy.
Pruller J; Hofer I; Ganassi M; Heher P; Ma MT; Zammit PS
Cancer Gene Ther; 2021 May; 28(5):427-441. PubMed ID: 32973362
[TBL] [Abstract][Full Text] [Related]
19. Stuck in a balancing act: histone methyltransferase activity of KMT1A traps alveolar rhabdomyosarcomas in an undifferentiated state.
MacQuarrie KL; Tapscott SJ
Cell Cycle; 2011 Oct; 10(19):3225-6. PubMed ID: 21941084
[No Abstract] [Full Text] [Related]
20. Pax7-FKHR transcriptional activity is enhanced by transcriptionally repressed MyoD.
Olguín HC; Patzlaff NE; Olwin BB
J Cell Biochem; 2011 May; 112(5):1410-7. PubMed ID: 21321994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
